{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-048524","form_type":"8-K","ticker":"LUDG","cik":"0001960262","company_name":"LUDWIG ENTERPRISES, INC.","filed_at":"2025-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.576905+00:00","generated_at":"2026-05-20T06:47:56.781928+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Ludwig Enterprises publishes ASCO abstract on non-invasive breast cancer mRNA test","bullets":["Abstract details mRNA signal from buccal cells combined with machine learning for breast cancer screening.","Study analyzed 48 mRNA cytokine biomarkers from non-invasive cheek swabs across 40 U.S. clinical centers.","Top biomarker system achieved F1-score of 0.9, precision 0.892, recall 0.913 (AUC 0.897).","Second system achieved F1-score of 0.892, precision 0.888, recall 0.902 (AUC 0.849).","Research presented at ASCO 2025 Annual Meeting; previously under embargo."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-048524","json":"https://secwatch.observer/filing/0001213900-25-048524.json","markdown":"https://secwatch.observer/filing/0001213900-25-048524.md","text":"https://secwatch.observer/filing/0001213900-25-048524.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1960262/000121390025048524/0001213900-25-048524-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1960262/000121390025048524/ea0243742-8k_ludwig.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T06:47:56.781928+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}